The dreams of Indian pharma majors to reap a windfall from the life saving drugs market in Thailand, following the Thai government’s issue of compulsory license, is set to hit a major roadblock. Emcure Pharmaceuticals, the first company which bagged a major order from the Thai government to supply clopidogrel, the copycat version of the blockbuster cardiac drug, Plavix, is being threatened by the US drug giant, Sanofi-Aventis, the patent holder of Plavix, with legal action…According to Vichai Chokevivat, chairman of the [Government Pharmaceutical Organisation] board, Sanofi's notice is the latest attempt by the drug giant to obstruct Thailand's compulsory licensing moves…